MedTrace Logo

Effect of Tibet Rhodiola Capsule on Hypoxia and Cardiovascular Risk Factors in Patients With Obstructive Sleep Apnea

NCT03163615 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-07-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of Tibet Rhodiola Capsule on hypoxia and the cardiovascular risk factors in patients with mild to moderate OSA.

Conditions

Interventions

DRUG

Tibet Rhodiola Capsule

4 capsules, po, from admission up to 84 days

DRUG

Placebo oral capsule

4 capsules, po, from admission up to 84 days

Sponsors & Collaborators

  • Shao-Ping Nie

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-17
Primary Completion
2018-02-28
Completion
2018-05-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03163615 on ClinicalTrials.gov